PRGN-2012

· Precigen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRGN-2012, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis [Phase 1, Phase 2]